A potent, selective, and cell-permeable inhibitor of the BRPF1 bromodomain (IC<sub>50</sub> = 80 nM) disrupts chromatin binding of BRPF1 in a cellular assay by blocking the interaction of BRPF1 with histone H3.3.
A potent, selective, and cell-permeable inhibitor of the BRPF1 bromodomain (IC<sub>50</sub> = 80 nM) disrupts chromatin binding of BRPF1 in a cellular assay by blocking the interaction of BRPF1 with histone H3.3.
A potent, reversible, ATP-competitive, thiazolidinedione inhibitor of PI3K&alpha (IC50 = 2 nM) and the common activating mutants of p100&alpha (E542K, E545K, and H1047R) found in cancer prevents proliferation in BT474 tumor xenografts and reduces
A potent, reversible, ATP-competitive, thiazolidinedione inhibitor of PI3K&alpha (IC50 = 2 nM) and the common activating mutants of p100&alpha (E542K, E545K, and H1047R) found in cancer prevents proliferation in BT474 tumor xenografts and reduces
A chemical probe for PRMT5 that potently inhibits the PRMT5/MEP50 complex from methylating histone H4 (IC<sub>50</sub> = 11 nM) in vitro inhibits the symmetric arginine methylation of SmD3 (EC<sub>50</sub> = 56 nM) in Z-138 cells.
A chemical probe for PRMT5 that potently inhibits the PRMT5/MEP50 complex from methylating histone H4 (IC<sub>50</sub> = 11 nM) in vitro inhibits the symmetric arginine methylation of SmD3 (EC<sub>50</sub> = 56 nM) in Z-138 cells.
A small molecule inhibitor of JAK2 (IC<sub>50</sub> = 6 nM) and the related kinases FLT3 (IC<sub>50</sub> = 25 nM) and RET (IC<sub>50</sub> = 17 nM) with significantly less potent activity against JAK3 (IC<sub>50</sub> = 169 nM) inhibits the growth
A small molecule inhibitor of JAK2 (IC<sub>50</sub> = 6 nM) and the related kinases FLT3 (IC<sub>50</sub> = 25 nM) and RET (IC<sub>50</sub> = 17 nM) with significantly less potent activity against JAK3 (IC<sub>50</sub> = 169 nM) inhibits the growth
A potent, selective, and cell-permeable inhibitor of the BRPF1 bromodomain (IC<sub>50</sub> = 80 nM) disrupts chromatin binding of BRPF1 in a cellular assay by blocking the interaction of BRPF1 with histone H3.3.
A potent, selective, and cell-permeable inhibitor of the BRPF1 bromodomain (IC<sub>50</sub> = 80 nM) disrupts chromatin binding of BRPF1 in a cellular assay by blocking the interaction of BRPF1 with histone H3.3.
Nicotinamide adenine dinucleotide (NAD) exists in an oxidized form, NAD+, as well as a reduced form, NADH. NAD, the main free form in cells, functions in modulating cellular redox status and by controlling signaling and transcriptional events,
Nicotinamide adenine dinucleotide (NAD) exists in an oxidized form, NAD+, as well as a reduced form, NADH. NAD, the main free form in cells, functions in modulating cellular redox status and by controlling signaling and transcriptional events,
Glucose-6-phosphate dehydrogenase (G6PDH) is a cytosolic enzyme that catalyzes the first step in the pentose phosphate pathway. This pathway includes converting glucose to ribose-5-phosphate, a precursor to RNA, DNA, ATP, CoA, NAD, and FAD.
Glucose-6-phosphate dehydrogenase (G6PDH) is a cytosolic enzyme that catalyzes the first step in the pentose phosphate pathway. This pathway includes converting glucose to ribose-5-phosphate, a precursor to RNA, DNA, ATP, CoA, NAD, and FAD.
Cayman&rsquos HDAC Cell-Based Assay provides an easy tool for studying HDAC activity modulators in whole cells. By using a cell-permeable HDAC substrate, the activity of various protein lysine-specific deacetylases, including HDAC1-containing
Cayman&rsquos HDAC Cell-Based Assay provides an easy tool for studying HDAC activity modulators in whole cells. By using a cell-permeable HDAC substrate, the activity of various protein lysine-specific deacetylases, including HDAC1-containing
Pyruvate (pyruvic acid) is a key intermediate in cellular metabolic pathways and is derived primarily from glucose via glycolysis. Abnormal blood pyruvate levels are reported in a number of disorders including shock, liver disease, congestive heart
Pyruvate (pyruvic acid) is a key intermediate in cellular metabolic pathways and is derived primarily from glucose via glycolysis. Abnormal blood pyruvate levels are reported in a number of disorders including shock, liver disease, congestive heart
Cayman&rsquos Glycolysis Cell-Based Assay Kit provides a colorimetric method for detecting extracellular L-lactate, the end product of glycolysis, in cultured cells. In the assay, lactate dehydrogenase catalyzes the oxidation of lactate to
Cayman&rsquos Glycolysis Cell-Based Assay Kit provides a colorimetric method for detecting extracellular L-lactate, the end product of glycolysis, in cultured cells. In the assay, lactate dehydrogenase catalyzes the oxidation of lactate to
Cayman&rsquos TMRE Mitochondrial Membrane Potential Assay Kit utilizes tetramethylrhodamine ethyl ester (TMRE), a cell permeable, cationic dye which accumulates in the mitochondrial matrix based on mitochondrial membrane potential (&Delta&psiM).
Cayman&rsquos TMRE Mitochondrial Membrane Potential Assay Kit utilizes tetramethylrhodamine ethyl ester (TMRE), a cell permeable, cationic dye which accumulates in the mitochondrial matrix based on mitochondrial membrane potential (&Delta&psiM).